Nearly every case of monkeypox reported in New York City has been in a man.
The shortfall, which CDC Director Rochelle Walensky described as “frustrating,” comes as the U.S. has recorded 1,470 monkeypox cases, up from 45 cases on June 10. The U.S. cases are part of a global outbreak that has been widening since May and now includes more than 11,000 confirmed cases in 55 countries.
The Department of Health and Human Services, which oversees the Strategic National Stockpile, said it had so far distributed about 156,000 doses of Jynneos, the two-dose FDA-approved monkeypox vaccine, and that another 131,000 doses are available. The U.S. is also working with the Danish manufacturer, Bavarian Nordic, to accept delivery of another 786,000 Jynneos doses currently stored in Denmark. HHS will preposition those doses in the U.S., and they will become available for distribution once the FDA signs off on the company’s facility. That approval is expected by the end of the month, according to Dawn O’Connell, the HHS official who leads the office that oversees the U.S. strategic national stockpile.